Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: rebecca who wrote (435)	10/20/1998 12:09:00 AM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 939

I like Human Genome Sciences. Lets face it they are patenting genes and there is insider buying there recently too: HGSI- $2,511,908, 99,800 shares, 5 - B,B,B,D,B, 09/17/98-09/03/98 Average price: $25.17 How about Liposome? Check out the profile on LIPO. It is very similar to Sequus Pharmacueticals which was just purchased by ALZA for roughly twice the price. How about EMIS? It's not happening overnight but they have the ability to coat drugs that have to be injected so they can be delivered orally instead. Imagine heparin or insulin in an oral form. Did you read the latest copy of Individual Investor? There is a pretty nice story on the biotechs, pointing out what you already know: There is money being made right now from investments in the sector. No losers on this list today: quote.yahoo.com Regards, Jeff